ENROLLING_BY_INVITATION

Health eHeart BioBank

Talk to us

Conditions

Heart DiseasesCardiac DiseasesVascular DiseasesCardiovascular DiseasesHeart DiseaseCardiovascular DiseaseCardiology

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the Health eHeart BioBank is to collect and store specimen (e.g. blood, DNA, tissue) for future studies at the University of California, San Francisco (UCSF) that will help determine changes and identify molecular and genetic markers in the human body that might help increase our knowledge of heart disease and guide development of new diagnostic tools and treatments that may help rapidly detect heart disease and prevent and/or treat heart disease.

Official Title

Health eHeart BioBank

Quick Facts

Study Start:2025-04-01
Study Completion:2035-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ENROLLING_BY_INVITATION

Study ID

NCT06976502

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18 years or older.
  2. * Established patient seen at UCSF and/or is a current participant in a clinical study that utilizes the HeH BioBank for biospecimen collection.
  3. * Family member of a patient with cardiovascular disease.
  4. * Patient with no cardiovascular disease.
  1. * Unwilling to consent to biospecimen collection through the HeH BioBank.

Contacts and Locations

Principal Investigator

Jeffrey E Olgin, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Gregory Marcus, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Vasanth Vedantham, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Connor G O'Brien, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
James P Pirruccello, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, San Francisco
San Francisco, California, 94158
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Jeffrey E Olgin, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Gregory Marcus, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Vasanth Vedantham, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Connor G O'Brien, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • James P Pirruccello, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-01
Study Completion Date2035-12

Study Record Updates

Study Start Date2025-04-01
Study Completion Date2035-12

Terms related to this study

Keywords Provided by Researchers

  • Heart Disease
  • Cardiovascular Disease
  • Cardiology

Additional Relevant MeSH Terms

  • Heart Diseases
  • Cardiac Diseases
  • Vascular Diseases
  • Cardiovascular Diseases